Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A2 with anti-inflammatory activity
- 213 Downloads
The halo 6-fatty acid esters of l-ascorbic acid 3a, 3b and 6-fatty acid esters of l-ascorbic acid 5a–g were achieved from l-ascorbic acid 1. Compounds 3a, 3b and 5a–g were evaluated for anti-oxidant, anti-lipid peroxidation, and secretory phospholipase A2 (sPLA2) inhibition in vitro, and sPLA2 induced mouse paw edema. All the derivatives retained their anti-oxidant property compared to ascorbic acid at 6 × 10−4M and are good inhibitors of lipid peroxidation at 1 mg ml−1 as evaluated by 2, 2-Diphenyl-1-picrylhydrazyl radical and thio-barbituric acid methods, respectively. Compounds 5e and 5f significantly inhibited purified group I sPLA2 from Naja naja and group II sPLA2 from Vipera russelli, human synovial fluid and human pleural fluid with IC50 value ranging from 64 ± 1.95 to 82 ± 1.3 and 48 ± 2.27 to 61 ± 2.23 μM, respectively. The compounds 5e and 5f also showed varying degree of potency in neutralizing indirect hemolytic activity of sPLA2 at 50 μM concentration, and sPLA2 induced mouse paw edema at the dose 3 mg/kg. Further docking studies also confirmed that compounds 5e and 5f have maximum interaction with increasing negative energy value. Single molecule possessing both anti-oxidant and anti-inflammatory activities is of great therapeutic significance in inflammatory disorders.
Keywords6-fatty acid esters of l-ascorbic acid sPLA2 Anti-inflammatory activity Docking Anti-oxidant
Author expresses his sincere gratitude to the Lady Tata Memorial Trust, Mumbai for financial assistance, and the University of Mysore, Mysore, for providing laboratory facilities. We extend our thanks to Dr. C R Nagendran, Professor (retired), Dept of Botany, University of Mysore for the needful help in english correction.
- 1.Burke JE, Dennis EA (2009) Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res 50 Suppl: S237–S242Google Scholar
- 12.Chandra V, Jasti J, Kaur P, Dey S, Srinivasan A, Betzel Ch, Singh TP (2002) Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell’s viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS). Acta Crystallogr D Biol Crystallogr 58(Pt 10 Pt 2):1813–1819CrossRefPubMedGoogle Scholar
- 23.Halliwell B, Gutteridge JMC (1989) Free radicals in Biology and Medicine, 2nd edn. Clarendon Press, OxfordGoogle Scholar
- 30.Yamakawa MM, Hokama NZ (1976) In: A. Ohsaka, K. Hayashi, Y Sawai (eds) Animal, Plant and microbial toxins, vol 1. Plenum press, New York, p 97Google Scholar
- 38.Virupakshaiah DBM, Chandrakanth K, Rachanagouda P, Prasad H (2007) Computer Aided Docking Studies on Antiviral Drugs for SARS. Proceedings of world academy of science, engineering and technology 24: 307–6884Google Scholar